HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Shuen Lu Hung, Wen Hung Chung, Lieh Bang Liou, Chen Chung Chu, Marie Lin, Hsien Ping Huang, Yen Ling Lin, Joung Liang Lan, Li Cheng Yang, Hong Shang Hong, Ming Jing Chen, Ping Chin Lai, Mai Szu Wu, Chia Yu Chu, Kuo Hsien Wang, Chien Hsiun Chen, Cathy S J Fann, Jer Yuarn Wu, Yuan Tsong Chen

Research output: Contribution to journalArticle

809 Citations (Scopus)

Abstract

Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cause of severe cutaneous adverse reactions (SCAR), which include the drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The adverse events are unpredictable and carry significant morbidity and mortality. To identify genetic markers for allopurinol-SCAR, we carried out a case-control association study. We enrolled 51 patients with allopurinol-SCAR and 228 control individuals (135 allopurinol-tolerant subjects and 93 healthy subjects from the general population), and genotyped for 823 SNPs in genes related to drug metabolism and immune response. The initial screen revealed strong association between allopurinol-SCAR and SNPs in the MHC region, including BAT3 (encoding HLA-B associated transcript 3), MSH5 (mutS homolog 5), and MICB (MHC class I polypeptide-related sequence B) (P <10-7). We then determined the alleles of HLA loci A, B, C, and DRB1. The HLA-B*5801 allele was present in all (100%) 51 patients with allopurinol-SCAR, but only in 20 (15%) of 135 tolerant patients [odds ratio 580.3 (95% confidence interval, 34.4-9780.9); corrected P value = 4.7 × 10-24] and in 19 (20%) of 93 of healthy subjects [393.51 (23.23-6665.26); corrected P value = 8.1 × 10-18]. HLA alleles A*3303, Cw*0302, and DRB1*0301 were in linkage disequilibrium and formed an extended haplotype with HLA-B*5801. Our results indicated that allopurinol-SCAR is strongly associated with a genetic predisposition in Han Chinese. In particular, HLA-B*5801 allele is an important genetic risk factor for this life-threatening condition.

Original languageEnglish
Pages (from-to)4134-4139
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number11
DOIs
Publication statusPublished - Mar 15 2005

Fingerprint

Allopurinol
HLA-B Antigens
Genetic Markers
Alleles
Skin
HLA-A*33 antigen
Single Nucleotide Polymorphism
Healthy Volunteers
Drug Hypersensitivity Syndrome
Hyperuricemia
Stevens-Johnson Syndrome
Gout
Linkage Disequilibrium
Genetic Predisposition to Disease
Haplotypes
Case-Control Studies
Odds Ratio
Confidence Intervals
Morbidity
Peptides

Keywords

  • Adverse drug reactions
  • Genetic polymorphism
  • Pharmacogenetics
  • Stevens-Johnson syndrome
  • Toxic epidermal necrolysis

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. / Hung, Shuen Lu; Chung, Wen Hung; Liou, Lieh Bang; Chu, Chen Chung; Lin, Marie; Huang, Hsien Ping; Lin, Yen Ling; Lan, Joung Liang; Yang, Li Cheng; Hong, Hong Shang; Chen, Ming Jing; Lai, Ping Chin; Wu, Mai Szu; Chu, Chia Yu; Wang, Kuo Hsien; Chen, Chien Hsiun; Fann, Cathy S J; Wu, Jer Yuarn; Chen, Yuan Tsong.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 11, 15.03.2005, p. 4134-4139.

Research output: Contribution to journalArticle

Hung, SL, Chung, WH, Liou, LB, Chu, CC, Lin, M, Huang, HP, Lin, YL, Lan, JL, Yang, LC, Hong, HS, Chen, MJ, Lai, PC, Wu, MS, Chu, CY, Wang, KH, Chen, CH, Fann, CSJ, Wu, JY & Chen, YT 2005, 'HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol', Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 11, pp. 4134-4139. https://doi.org/10.1073/pnas.0409500102
Hung, Shuen Lu ; Chung, Wen Hung ; Liou, Lieh Bang ; Chu, Chen Chung ; Lin, Marie ; Huang, Hsien Ping ; Lin, Yen Ling ; Lan, Joung Liang ; Yang, Li Cheng ; Hong, Hong Shang ; Chen, Ming Jing ; Lai, Ping Chin ; Wu, Mai Szu ; Chu, Chia Yu ; Wang, Kuo Hsien ; Chen, Chien Hsiun ; Fann, Cathy S J ; Wu, Jer Yuarn ; Chen, Yuan Tsong. / HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 11. pp. 4134-4139.
@article{b9f9d2a540104804945020601dc5d86d,
title = "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
abstract = "Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cause of severe cutaneous adverse reactions (SCAR), which include the drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The adverse events are unpredictable and carry significant morbidity and mortality. To identify genetic markers for allopurinol-SCAR, we carried out a case-control association study. We enrolled 51 patients with allopurinol-SCAR and 228 control individuals (135 allopurinol-tolerant subjects and 93 healthy subjects from the general population), and genotyped for 823 SNPs in genes related to drug metabolism and immune response. The initial screen revealed strong association between allopurinol-SCAR and SNPs in the MHC region, including BAT3 (encoding HLA-B associated transcript 3), MSH5 (mutS homolog 5), and MICB (MHC class I polypeptide-related sequence B) (P <10-7). We then determined the alleles of HLA loci A, B, C, and DRB1. The HLA-B*5801 allele was present in all (100{\%}) 51 patients with allopurinol-SCAR, but only in 20 (15{\%}) of 135 tolerant patients [odds ratio 580.3 (95{\%} confidence interval, 34.4-9780.9); corrected P value = 4.7 × 10-24] and in 19 (20{\%}) of 93 of healthy subjects [393.51 (23.23-6665.26); corrected P value = 8.1 × 10-18]. HLA alleles A*3303, Cw*0302, and DRB1*0301 were in linkage disequilibrium and formed an extended haplotype with HLA-B*5801. Our results indicated that allopurinol-SCAR is strongly associated with a genetic predisposition in Han Chinese. In particular, HLA-B*5801 allele is an important genetic risk factor for this life-threatening condition.",
keywords = "Adverse drug reactions, Genetic polymorphism, Pharmacogenetics, Stevens-Johnson syndrome, Toxic epidermal necrolysis",
author = "Hung, {Shuen Lu} and Chung, {Wen Hung} and Liou, {Lieh Bang} and Chu, {Chen Chung} and Marie Lin and Huang, {Hsien Ping} and Lin, {Yen Ling} and Lan, {Joung Liang} and Yang, {Li Cheng} and Hong, {Hong Shang} and Chen, {Ming Jing} and Lai, {Ping Chin} and Wu, {Mai Szu} and Chu, {Chia Yu} and Wang, {Kuo Hsien} and Chen, {Chien Hsiun} and Fann, {Cathy S J} and Wu, {Jer Yuarn} and Chen, {Yuan Tsong}",
year = "2005",
month = "3",
day = "15",
doi = "10.1073/pnas.0409500102",
language = "English",
volume = "102",
pages = "4134--4139",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "11",

}

TY - JOUR

T1 - HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

AU - Hung, Shuen Lu

AU - Chung, Wen Hung

AU - Liou, Lieh Bang

AU - Chu, Chen Chung

AU - Lin, Marie

AU - Huang, Hsien Ping

AU - Lin, Yen Ling

AU - Lan, Joung Liang

AU - Yang, Li Cheng

AU - Hong, Hong Shang

AU - Chen, Ming Jing

AU - Lai, Ping Chin

AU - Wu, Mai Szu

AU - Chu, Chia Yu

AU - Wang, Kuo Hsien

AU - Chen, Chien Hsiun

AU - Fann, Cathy S J

AU - Wu, Jer Yuarn

AU - Chen, Yuan Tsong

PY - 2005/3/15

Y1 - 2005/3/15

N2 - Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cause of severe cutaneous adverse reactions (SCAR), which include the drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The adverse events are unpredictable and carry significant morbidity and mortality. To identify genetic markers for allopurinol-SCAR, we carried out a case-control association study. We enrolled 51 patients with allopurinol-SCAR and 228 control individuals (135 allopurinol-tolerant subjects and 93 healthy subjects from the general population), and genotyped for 823 SNPs in genes related to drug metabolism and immune response. The initial screen revealed strong association between allopurinol-SCAR and SNPs in the MHC region, including BAT3 (encoding HLA-B associated transcript 3), MSH5 (mutS homolog 5), and MICB (MHC class I polypeptide-related sequence B) (P <10-7). We then determined the alleles of HLA loci A, B, C, and DRB1. The HLA-B*5801 allele was present in all (100%) 51 patients with allopurinol-SCAR, but only in 20 (15%) of 135 tolerant patients [odds ratio 580.3 (95% confidence interval, 34.4-9780.9); corrected P value = 4.7 × 10-24] and in 19 (20%) of 93 of healthy subjects [393.51 (23.23-6665.26); corrected P value = 8.1 × 10-18]. HLA alleles A*3303, Cw*0302, and DRB1*0301 were in linkage disequilibrium and formed an extended haplotype with HLA-B*5801. Our results indicated that allopurinol-SCAR is strongly associated with a genetic predisposition in Han Chinese. In particular, HLA-B*5801 allele is an important genetic risk factor for this life-threatening condition.

AB - Allopurinol, a commonly prescribed medication for gout and hyperuricemia, is a frequent cause of severe cutaneous adverse reactions (SCAR), which include the drug hypersensitivity syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The adverse events are unpredictable and carry significant morbidity and mortality. To identify genetic markers for allopurinol-SCAR, we carried out a case-control association study. We enrolled 51 patients with allopurinol-SCAR and 228 control individuals (135 allopurinol-tolerant subjects and 93 healthy subjects from the general population), and genotyped for 823 SNPs in genes related to drug metabolism and immune response. The initial screen revealed strong association between allopurinol-SCAR and SNPs in the MHC region, including BAT3 (encoding HLA-B associated transcript 3), MSH5 (mutS homolog 5), and MICB (MHC class I polypeptide-related sequence B) (P <10-7). We then determined the alleles of HLA loci A, B, C, and DRB1. The HLA-B*5801 allele was present in all (100%) 51 patients with allopurinol-SCAR, but only in 20 (15%) of 135 tolerant patients [odds ratio 580.3 (95% confidence interval, 34.4-9780.9); corrected P value = 4.7 × 10-24] and in 19 (20%) of 93 of healthy subjects [393.51 (23.23-6665.26); corrected P value = 8.1 × 10-18]. HLA alleles A*3303, Cw*0302, and DRB1*0301 were in linkage disequilibrium and formed an extended haplotype with HLA-B*5801. Our results indicated that allopurinol-SCAR is strongly associated with a genetic predisposition in Han Chinese. In particular, HLA-B*5801 allele is an important genetic risk factor for this life-threatening condition.

KW - Adverse drug reactions

KW - Genetic polymorphism

KW - Pharmacogenetics

KW - Stevens-Johnson syndrome

KW - Toxic epidermal necrolysis

UR - http://www.scopus.com/inward/record.url?scp=15244349566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15244349566&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409500102

DO - 10.1073/pnas.0409500102

M3 - Article

C2 - 15743917

AN - SCOPUS:15244349566

VL - 102

SP - 4134

EP - 4139

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -